Pulmonary Cell News 8.39 October 10, 2019 | |
| |
TOP STORYScientists identified a novel phosphoglycerate mutase 1 (PGAM1) allosteric inhibitor, HKB99, via structure-based optimization. HKB99 acted to allosterically block conformational change of PGAM1 during catalytic process and PGAM1-ACTA2 interaction. HKB99 suppressed tumor growth and metastasis and overcame erlotinib resistance in non-small-cell lung cancer. [Cell Metab] Abstract | Graphical Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Lung cancer-derived extracellular vesicles induced transcription of the pri-miR-92a gene, resulting in the overexpression of mature miR-19b and miR-92a in recipient bronchial cells. Modulation of these two miRNAs using miRNA mimics or inhibitors confirmed their ability to promote proliferation. [Cell Death Dis] Full Article Scientists showed that surfactant-secreting type 2 (AT2) cells were the primary source of stretch-induced ATP release in heterocellular AT2/AT1 cell cultures, suggesting similar contribution in intact alveoli. [Am J Physiol Lung Cell Mol Physiol] Abstract The authors hypothesised that the DNA methylation profiles of cultured primary airway epithelial cells would differ between cells isolated from individuals with asthma versus those without asthma. [Sci Rep] Full Article Cigarette smoke extract treatment differentially affected mitochondrial function, such as membrane potential, mitochondrial reactive oxygen species and mitochrondrial mass as analyzed by FACS, and were associated with altered oxidative phosphorylation proteins levels in primary lung epithelial cells, and in BEAS2B cells. [Toxicol Lett] Abstract | Graphical Abstract Transforming growth factor destabilized CF transmembrane conductance regulator (CFTR) mRNA in cells from lungs with chronic disease, including CF, and impaired F508del-CFTR rescue by new-generation correctors. [Int J Mol Sci] Abstract Researchers detected the release of inflammatory factors that revealed a negative correlation between organic cation transporter (OCTN)1/2 down-regulation and inflammation in human alveolar epithelial cells exposed to different concentrations of lipopolysaccharide (LPS). [J Drug Target] Abstract LUNG CANCERSimulated Microgravity with Floating Environment Promotes Migration of Non-Small Cell Lung Cancers Investigators evaluated the proliferation and migration of two types of non-small cell lung cancers in a floating environment with microgravity. [Sci Rep] Full Article LINC00243 knockdown inhibited proliferation and glycolysis of non-small cell lung cancer (NSCLC) cells. Mechanically, LINC00243 acted as a molecular sponge for miR-507, and miR-507 reversed the effect of LINC00243 on promoting proliferation and glycolysis of NSCLC cells. [Mol Cell Biochem] Abstract Subscribe to one of our other 19 science newsletters such as Cancer Stem Cell News & Human Immunology News. | |
| |
REVIEWSBronchopulmonary dysplasia (BPD) is the most common cause of morbidity and mortality in preterm infants. A key histopathological feature of BPD is stunted late lung development, where the process of alveolarization -the generation of alveolar gas exchange units- is impeded, through mechanisms that remain largely unclear. [Am J Physiol Lung Cell Mol Physiol] Abstract Visit our reviews page to see a complete list of reviews in the pulmonary cell research field. | |
| |
INDUSTRY NEWSAstraZeneca announced that the FDA has approved the self-administration of Fasenra in a pre-filled, single-use auto-injector. [AstraZeneca] Press Release Boehringer Ingelheim announced that the FDA granted Breakthrough Therapy Designation to Ofev®, which is currently under FDA review for the treatment of people with chronic fibrosing interstitial lung diseases (ILDs) with a progressive phenotype. [Boehringer Ingelheim (PR Newswire Association LLC.)] Press Release MediciNova, Inc. announced that it has received a Notice of Allowance from the Japan Patent Office for a pending patent application which covers MN-001 and MN-002 for the treatment of idiopathic pulmonary fibrosis. [MediciNova, Inc.] Press Release | |
| |
POLICY NEWSDrug Tailored to One Girl with Brain Disease Paves Way for Similar Customized Treatments After their apparent success treating a young girl with a drug tailored to counteract a genetic mutation that had given her a usually fatal brain disease, the researchers behind the innovative strategy have this week laid out criteria for similarly helping more sick children. [ScienceInsider] Editorial Biologists Who Decoded How Cells Sense Oxygen Win Medicine Nobel A trio of researchers has won the 2019 Nobel Prize in Physiology or Medicine for describing how cells sense and respond to changing oxygen levels by switching genes on and off — a discovery that has been key in understanding human diseases such as cancer and anemia. [Nature News] Editorial
| |
EVENTSNEW Tumor Immunology and Immunotherapy Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Postdoctoral Research Fellow – Lung Development and Disease (Center for Regenerative Medicine) NEW Postdoctoral Scholarship – Cancer Biology (Lund University) Research Fellow – Lung Cancer (Dana-Farber Cancer Institute) Faculty Position – Pulmonary and Critical Care Medicine (Mayo Clinic Comprehensive Cancer Center) Research Scientist – Fibrosis (Gilead Sciences, Inc.) Postdoctoral Positions – Sepsis and Pulmonary Injury (University of Maryland) Postdoctoral Position – Small Cell Lung Cancer (Fred Hutchinson Cancer Research Center) Postdoctoral Position – Lung Inflammation (The Boston University Pulmonary Center) Associate Director – Pulmonary Biology (Translate Bio, Inc.) Postdoctoral Fellowship – Lung Epithelium (Boston University) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Pulmonary Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|